Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Glia ; 63(9): 1621-35, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25847153

ABSTRACT

Oligodendrocytes, the myelin forming cells of the CNS, are characterized by their numerous membranous extensions, which enwrap neuronal axons and form myelin sheaths. During differentiation oligodendrocytes pass different morphological stages, downregulate the expression of the proteoglycan NG2, and acquire major myelin specific proteins, such as myelin basic proteins (MBP) and proteolipid protein. MBP mRNA is transported in RNA granules along the microtubules (MTs) to the periphery and translated locally. MTs participate in the elaboration and stabilization of the myelin forming extensions and are essential for cellular sorting processes. Their dynamic properties are regulated by microtubule associated proteins (MAPs). The MAP tau is present in oligodendrocytes and involved in the regulation and stabilization of the MT network. To further elucidate the functional significance of tau in oligodendrocytes, we have downregulated tau by siRNA technology and studied the effects on cell differentiation and neuron-glia contact formation. The data show that tau knockdown impairs process outgrowth and leads to a decrease in MBP expression. Furthermore, MBP mRNA transport to distant cellular extensions is impaired and cells remain in the NG2 stage. In myelinating cocultures with dorsal root ganglion neurons, oligodendrocyte precursor cells after tau miR RNA lentiviral knockdown develop into NG2 positive cells with very long and thin processes, contacting axons loosely, but fail to form internodes. This demonstrates that tau is important for MBP mRNA transport and involved in process formation. The disturbance of the balance of tau leads to abnormalities in oligodendrocyte differentiation, neuron-glia contact formation and the early myelination process.


Subject(s)
Myelin Basic Protein/metabolism , Oligodendroglia/metabolism , RNA Transport/physiology , RNA, Messenger/metabolism , tau Proteins/metabolism , Animals , Brain/metabolism , Cell Line , Cells, Cultured , Coculture Techniques , Down-Regulation , Ganglia, Spinal/metabolism , Humans , Microtubules/metabolism , Myelin Sheath/metabolism , Neurons/metabolism , Proto-Oncogene Proteins c-fyn/metabolism , Rats, Wistar , Tubulin/metabolism , tau Proteins/genetics
2.
Nat Commun ; 4: 1335, 2013.
Article in English | MEDLINE | ID: mdl-23299885

ABSTRACT

Cultures of human embryonic stem cell typically rely on protein matrices or feeder cells to support attachment and growth, while mechanical, enzymatic or chemical cell dissociation methods are used for cellular passaging. However, these methods are ill defined, thus introducing variability into the system, and may damage cells. They also exert selective pressures favouring cell aneuploidy and loss of differentiation potential. Here we report the identification of a family of chemically defined thermoresponsive synthetic hydrogels based on 2-(diethylamino)ethyl acrylate, which support long-term human embryonic stem cell growth and pluripotency over a period of 2-6 months. The hydrogels permitted gentle, reagent-free cell passaging by virtue of transient modulation of the ambient temperature from 37 to 15 °C for 30 min. These chemically defined alternatives to currently used, undefined biological substrates represent a flexible and scalable approach for improving the definition, efficacy and safety of human embryonic stem cell culture systems for research, industrial and clinical applications.


Subject(s)
Cell Culture Techniques/methods , Embryonic Stem Cells/cytology , Embryonic Stem Cells/drug effects , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Hydrogel, Polyethylene Glycol Dimethacrylate/pharmacology , Temperature , Biophysical Phenomena/drug effects , Cell Adhesion/drug effects , Cells, Cultured , Collagen/pharmacology , Colony-Forming Units Assay , Culture Media/pharmacology , Drug Combinations , Electrophoresis, Polyacrylamide Gel , Humans , Laminin/pharmacology , Proteoglycans/pharmacology , Stress, Mechanical , Time Factors
3.
J Neurochem ; 113(2): 465-76, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20096089

ABSTRACT

Polyunsaturated fatty acids (PUFA) are highly abundant in brain tissue, and docosahexaenoic acid (DHA) might protect cells from oxidative stress (OS) during inflammation and demyelinating disorders, but also might exert pro-oxidant effects. Here we investigated if PUFA supplements lead to heat shock protein induction, altered cell survival properties and stress responses to OS exerted by hydrogen peroxide in oligodendroglial OLN-93 cells. The data show that supplements of various fatty acids (FA) with 18-22 carbons chain length and 2-6 double bonds led to PUFA enrichment in cellular membranes. Depending on the degree of desaturation, FA-supplements caused the up-regulation of heme oxygenase-1 (HSP32), a stress protein inducible by OS, and an increase in sensitivity to hydrogen peroxide-treatment. DHA, with the highest number of double bonds, was most effective. Co-treatment with DHA and the lipophilic vitamin E analogue alpha-tocopherol, suppressed heme oxygenase-1 up-regulation and cell survival was restored. Analysis of the lipid profile demonstrates that alpha-tocopherol not only has antioxidant capacities, but also directly modified the PUFA profile in cell membranes. Enrichment with higher omega-3, -6 and -9 PUFA and an increase in the biosynthesis rate of very long chain fatty acids, mainly changed the FA profile of ethanolamine and serine phosphoglycerides.


Subject(s)
Fatty Acids, Unsaturated/pharmacology , Heme Oxygenase (Decyclizing)/metabolism , Membrane Lipids/metabolism , Oligodendroglia/cytology , Oxidative Stress/physiology , Up-Regulation/drug effects , Actins/metabolism , Animals , Antioxidants/pharmacology , Cell Death/drug effects , Cell Line, Transformed , Dose-Response Relationship, Drug , Heme Oxygenase (Decyclizing)/genetics , Hot Temperature , Hydrogen Peroxide/pharmacology , Oligodendroglia/drug effects , Oligodendroglia/metabolism , Oxidative Stress/drug effects , Rats , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors , Tubulin/metabolism , Up-Regulation/physiology , alpha-Tocopherol/pharmacology
4.
J Biol ; 8(8): 78, 2009 Sep 25.
Article in English | MEDLINE | ID: mdl-19804608

ABSTRACT

A recent report in BMC Cell Biology examines how the balance of extracellular forces and intracellular contractions regulate the shape changes required for oligodendrocyte myelination. A failure of remyelination such as seen in multiple sclerosis could be caused by loss of this balance.


Subject(s)
Multiple Sclerosis/pathology , Myelin Sheath/physiology , Regeneration , Animals , Cell Adhesion , Cell Shape , Extracellular Matrix/metabolism , Humans , Mechanotransduction, Cellular
5.
Glia ; 57(16): 1691-705, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19455583

ABSTRACT

Oligodendrocytes, the myelin-forming cells of the central nervous system, are in culture characterized by an elaborate process network, terminating in flat membranous sheets that are rich in myelin-specific proteins and lipids, and spirally wrap axons forming a compact insulating layer in vivo. By analogy with other cell types, maintenance and stability of these processes, as well as the formation of the myelin sheath, likely rely on a pronounced cytoskeleton consisting of microtubules and microfilaments. While the specialized process of wrapping and compaction forming the myelin sheath is not well understood, considerably more is known about how cytoskeletal organization is mediated by extracellular and intracellular signals and other interaction partners during oligodendrocyte differentiation and myelination. Here, we review the current state of knowledge on the role of the oligodendrocyte cytoskeleton in differentiation with an emphasis on signal transduction mechanisms and will attempt to draw out implications for its significance in myelination.


Subject(s)
Cell Differentiation/physiology , Cytoskeleton/physiology , Myelin Sheath/physiology , Oligodendroglia/physiology , Animals , Myelin Proteins/physiology , Signal Transduction/physiology
6.
J Mol Neurosci ; 29(2): 153-68, 2006.
Article in English | MEDLINE | ID: mdl-16954605

ABSTRACT

University of Oldenburg, Department of Biology, Molecular Neurobiology, D-26111 Oldenburg, Germany Ubiquitinated tau-positive inclusion bodies in oligodendrocytes are consistent features in a variety of neurodegenerative disorders, and their formation points to an underlying incapacity of the protein quality control system that normally prevents the accumulation of misfolded proteins. To study the consequences of proteasomal impairment, we have used an oligodendroglial cell line, namely OLN-t40 cells, genetically engineered to express the longest human tau isoform. Treatment of OLN-t40 cells with the proteasomal inhibitor MG-132 (0.5 microM, 18 h) caused the formation of large, nonfibrillary tau-positive aggregates containing the small HSP alphaB-crystallin and ubiquitin in the vicinity of the microtubule organizing center (MTOC). The sequestration of misfolded proteins into specialized regions, called aggresomes, in response to stress stimuli has been reported to be associated with a redistribution of intermediate filaments (IFs). In oligodendroglial cells, which do not contain a cytoplasmic IF system, aggresomelike inclusions were instead surrounded by bundles of MTs and contained clusters of mitochondria. Aggresome formation was prevented by both MT-stabilizing and -destabilizing drugs, indicating not only that an intact cytoskeleton but also the dynamic instability of the MT network is required. Furthermore, the binding of stress-induced alphaBcrystallin to the MTs points to a possible protective role during disease progression.


Subject(s)
Microtubules/metabolism , Oligodendroglia/metabolism , Oxidative Stress , Protein Isoforms/metabolism , tau Proteins/metabolism , Alternative Splicing , Cell Line , Crystallins/metabolism , Cysteine Proteinase Inhibitors/metabolism , Heat-Shock Proteins/metabolism , Humans , Inclusion Bodies/metabolism , Leupeptins/metabolism , Microtubule-Organizing Center/metabolism , Mitochondria/metabolism , Nocodazole/metabolism , Oligodendroglia/cytology , Paclitaxel/metabolism , Protein Isoforms/genetics , Tubulin Modulators/metabolism , Ubiquitin/metabolism , tau Proteins/genetics
7.
Int J Dev Neurosci ; 22(7): 443-51, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15465274

ABSTRACT

Filamentous tau-positive inclusions in neurons and glia are a unifying mechanism underlying a variety of late onset neurodegenerative disorders termed "tauopathies". Oligodendroglial lesions and white matter pathology have long been underestimated and are specifically prominent in frontotemporal dementias (FTDs), such as Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17). Oligodendrocytes contain an extensive microtubule network and express the microtubule-associated protein tau. Tau-positive inclusion bodies in oligodendrocytes are positively stained with antibodies against ubiquitin and heat shock proteins (HSPs). Specifically the small HSP alphaB-crystallin has been identified in oligodendroglial lesions. HSPs act as molecular chaperones and prevent the accumulation of abnormal proteins, and support proteolytic degradation by targeting non-reparable proteins to the ubiquitin proteasomal pathway. HSPs and the proteasomal system closely work together. The present report summarizes recent data on HSP induction and aggregate formation in oligodendroglia cell culture systems, indicating that posttranslational modification of tau, HSP induction and alterations of the proteasomal system, which might occur during aging and disease processes, are involved in the neuropathological events leading to aggregate formation and degeneration.


Subject(s)
Aging/metabolism , Heat-Shock Proteins/metabolism , Inclusion Bodies/metabolism , Neurodegenerative Diseases/metabolism , Oligodendroglia/metabolism , Proteasome Endopeptidase Complex/metabolism , tau Proteins/metabolism , Animals , Cytoskeleton/metabolism , Humans , Multiprotein Complexes/metabolism , Neuroglia/metabolism , Neurons/metabolism , Proteasome Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL